Altimmune News, Altimmune Quote, ALT Quote

Altimmune (NQ:ALT) Delayed: 3.42 +0.19 (5.88%)

Prev. Close

$3.23

Today 6M 1Y 5Y

Open

$3.28

52 Wk High

$54.24

52 Wk Low

$48.35

Day High

$3.43

Day Low

$3.25

P/E

N/A

EPS

$0.00

Volume

4,871,049

Friends, Peers and Foes (?): XFOR, DMRC, NUTX, QMCO, FIVE (more...)

ALERTS | RSS

Aug 13, 2026 04:05 PM Form 4 Altimmune, Inc. For: Aug 13 Filed by: Durso Jerome Benedict
Aug 12, 2026 04:04 PM Form 10-Q Altimmune, Inc. For: Jun 30
Aug 12, 2026 07:42 AM Altimmune, Inc. (ALT) Tops Q2 EPS by 3c
Aug 12, 2026 07:34 AM Form 8-K Altimmune, Inc. For: Aug 12
Aug 12, 2026 07:30 AM Altimmune Announces Second Quarter 2026 Financial Results and Business Update
Aug 5, 2026 08:00 AM Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
Aug 3, 2026 04:06 PM Form 4 Altimmune, Inc. For: Jul 31 Filed by: WEAVER GREGORY L
Aug 3, 2026 04:06 PM Form 4 Altimmune, Inc. For: Jul 31 Filed by: Roberts M Scot
Aug 3, 2026 08:01 AM Altimmune starts Phase 3 trial of pemvidutide for MASH
Aug 3, 2026 08:00 AM Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

Entities mentioned with ALT

View All Entities